Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High
Psychedelics like psilocybin and DMT minimally affect sleep-wake states but alter EEG spectral power and functional connectivity, particularly in the high gamma band during wakefulness and sleep.
Area of Science:
- Neuroscience
- Psychopharmacology
- Sleep Research
Background:
- Increasing recreational and therapeutic interest in psychedelics (psilocybin, DMT).
- Bidirectional relationship between sleep-wake states and mental health.
- Need to understand psychedelic effects on sleep and brain activity.
Purpose of the Study:
- Investigate the impact of psilocybin and DMT on sleep-wake states in rats.
- Analyze changes in EEG spectral power and functional connectivity.
Main Methods:
- Intravenous administration of psilocybin (2.5, 10 mg/kg) and DMT (3.75, 7.5 mg/kg) or saline to Sprague Dawley rats (n=25).
- High-density EEG and EMG recordings.
- Sleep scoring (wake, SWS, REM) and analysis of EEG spectral power and corticocortical coherence.
Main Results:
- Psilocybin and DMT delayed SWS and REM sleep onset, transiently increasing wakefulness and decreasing SWS.
- Psilocybin decreased REM sleep, altered theta and high gamma power/coherence during wake/SWS.
- DMT increased gamma coherence during wakefulness.
Conclusions:
- Serotonergic psychedelics show minimal impact on overall sleep-wake architecture.
- Enhanced high gamma functional connectivity indicates psychedelic effects on neural dynamics independent of arousal states.
More Related Videos
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
CNS Stimulants: Psychedelic Agents
Management of Insomnia
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
REM Sleep Behavior Disorder
RBD is significantly associated with...
